CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Astellas Pharma US Inc. recalls Prograf (tacrolimus) capsules and 1 more

Read the official FDA notice

Published
5 Feb 2025
Units affected
2 products
Agency
FDA
Country
United States

The hazard

Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules

Classification: Class I — the most serious type: there is a reasonable chance this product could cause serious health problems or death.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Prograf (tacrolimus) capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Product of Japan, Distributed by: Astellas Pharma US, Inc., Northbrook, IL 60062, NDC 0469-0607-73.

Astagraf XL (tacrolimus extended-release capsules) 0.5 mg, 30-count bottles, RX Only, Product of Japan, Distributed by: Astellas Pharma US Inc., Northbrook, IL 60062, NDC 0469-0647-73.

Brand / company
Astellas Pharma US Inc.
Codes / lots
Lot# 0E3353D, Exp 03/31/2026 | Lot# 0R3092A, EXP 03/31/2026
Distribution
Nationwide in the USA
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 5 Feb 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.